Question
  • Facebook
  • Twitter
    •

    • Your submission is now a Draft.

    Once it's ready, please submit your draft for review by our team of Community Moderators. Thank you!

    You have been invited to co-author this question.

    When it is ready, the author will submit it for review by Community Moderators. Thanks for helping!

    Pending

    This question now needs to be approved by community moderators.

    You have been invited to co-author this question.

    It now needs to be approved by community moderators. Thanks for helping!

    10M are administered an efficacious vaccine.

    Created by juancambeiro and
    co-authors , {{coauthor.username}}
    on {{qctrl.question.created_time | dateStr}}
    Cross-posted on Metaculus.

    The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus is a novel betacoronavirus that likely emerged late last year from an animal reservoir in China. There is little to no pre-existing immunity against it in the human population. The clinical picture for the disease it causes, coronavirus disease 2019 (COVID-19), ranges from very mild to fatal. The virus is highly transmissible and has spread globally.

    As of 20 March 2020, the World Health Organization (WHO) is reporting that it is tracking the development of forty-four SARS-CoV-2 candidate vaccines. Two of these candidates have entered phase one and the other forty-two remain in the pre-clinical stage. There is an urgent need to determine when the first of these candidates will have been found to have a high degree of efficacy and will have been administered to a significant number of people.

    The WHO defines vaccine efficacy as follows:

    Vaccine efficacy: % reduction in disease incidence in a vaccinated group compared to an unvaccinated group under optimal conditions

    This question asks: When will 10M people be administered a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT?

    This question resolves as the date when the first credible article is published that presents the claim that at least 10 million people have been administered a vaccine that had been previously shown to have an efficacy rate exceeding >75% in a randomized controlled trial with at least 500 participants.

    If this does not resolve before 08 April 2023, it resolves as >08 April 2023.

    The 10M people can receive different vaccines, as long as they all qualify by this question's criteria.

    Being administered a vaccine means having followed the treatment course that was tested in the RCT. If the vaccine needs several shots, then only people who have received all of them count.

    Edit on 2020-05-06: removed "outside a clinical trial" from the resolution language. Previous resolution language :

    This question resolves as the date when the first credible article is published that presents the claim that at least 10,000 people outside a clinical trial have been administered a vaccine that had been previously shown to have an efficacy rate exceeding >95% in a randomized controlled trial with at least 500 participants.

    Edit on 2020-11-21: Changed the title, question phrasing and added a caveat to allow several vaccines. Also added caveat about multi-shot vaccines.

    Categories:
    Internal Red Cross Second Wave Scenarios
    Salk Tournament for SARS-CoV-2 Vaccine R&D
    Medical Interventions Development
    Medical Interventions Research

    Note: this question resolved before its original close time. All of your predictions came after the resolution, so you did not gain (or lose) any points for it.

    Note: this question resolved before its original close time. You earned points up until the question resolution, but not afterwards.

    Current points depend on your prediction, the community's prediction, and the result. Your total earned points are averaged over the lifetime of the question, so predict early to get as many points as possible! See the FAQ.